FAQ

Multiple Sclerosis, Chronic Progressive

Known as: Chronic Progressive Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive [Disease/Finding] 
A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-2017
05101519732017

Related topics

Related topics

11 relations
Aspects of mortality statisticsIn BloodMicrobiologicalchemically induced
(More)

Broader (1)

Multiple Sclerosis

Narrower (3)

Multiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Progressive RelapsingMultiple Sclerosis, Secondary Progressive

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Multiple Sclerosis, Chronic Progressive
Multiple Sclerosis
prevention & control
In Blood
radiotherapeutic
nursing therapy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis.
The neurodegenerative aspects of chronic progressive multiple sclerosis (MS) have received increasing attention in recent years… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis.
Blood-brain barrier (BBB) breakdown, demonstrable in vivo by enhanced MRI is characteristic of new and expanding inflammatory… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
One of the hallmarks of the human demyelinating disease multiple sclerosis is the inability to compensate adequately for the loss… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
In experimental animal models of multiple sclerosis demyelinating antibody responses are directed against the myelin… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The treatment of chronic progressive multiple sclerosis with cladribine.
A 2-year, placebo-controlled, double-blind, crossover study was started in 1992 to evaluate cladribine, an immunosuppressive drug… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Cladribine in treatment of chronic progressive multiple sclerosis.
Chronic progressive multiple sclerosis (MS) is a severely disabling demyelinating disease in which autoimmune processes seem to… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis.
Magnetic resonance imaging is a highly sensitive method for the detection of the lesions of multiple sclerosis and renders… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Multiple sclerosis: remyelination in acute lesions.
Central nervous system (CNS) remyelination has been found by light and electron microscopy and immunocytochemistry within fresh… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
BACKGROUND Cachectin, or tumor necrosis factor-alpha (TNF-alpha), is a principal mediator of the inflammatory response and may be… (More)
Is this relevant?
Highly Cited
1984
Highly Cited
1984
Memory disturbance in chronic progressive multiple sclerosis.
Forty-four patients with chronic progressive multiple sclerosis (MS) were compared with age- and education-matched control groups… (More)
Is this relevant?